260 related articles for article (PubMed ID: 23257710)
1. Comparison of the effects between intravitreal and periocular injections of adenoviral vectored pigment epithelium-derived factor on suppressing choroidal neovascularization in rats.
Yan H; Cui J; Wang Y; Yu Y
Ophthalmic Res; 2013; 49(2):81-9. PubMed ID: 23257710
[TBL] [Abstract][Full Text] [Related]
2. [An experimental study on choroidal neovascularization inhibited by adenoviral vectored pigment epithelium-derived factor].
Yan H; Wang Y; Cui J; Yu YP
Zhonghua Yan Ke Za Zhi; 2008 May; 44(5):442-7. PubMed ID: 18953901
[TBL] [Abstract][Full Text] [Related]
3. Regression of ocular neovascularization in response to increased expression of pigment epithelium-derived factor.
Mori K; Gehlbach P; Ando A; McVey D; Wei L; Campochiaro PA
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2428-34. PubMed ID: 12091447
[TBL] [Abstract][Full Text] [Related]
4. Periocular gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization in a human-sized eye.
Saishin Y; Silva RL; Saishin Y; Kachi S; Aslam S; Gong YY; Lai H; Carrion M; Harris B; Hamilton M; Wei L; Campochiaro PA
Hum Gene Ther; 2005 Apr; 16(4):473-8. PubMed ID: 15871678
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of YC-1, 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole, on experimental choroidal neovascularization in rat.
Song SJ; Chung H; Yu HG
Ophthalmic Res; 2008; 40(1):35-40. PubMed ID: 18032914
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound-mediated microbubble delivery of pigment epithelium-derived factor gene into retina inhibits choroidal neovascularization.
Zhou XY; Liao Q; Pu YM; Tang YQ; Gong X; Li J; Xu Y; Wang ZG
Chin Med J (Engl); 2009 Nov; 122(22):2711-7. PubMed ID: 19951601
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA.
Gu L; Chen H; Tuo J; Gao X; Chen L
Exp Eye Res; 2010 Sep; 91(3):433-9. PubMed ID: 20599960
[TBL] [Abstract][Full Text] [Related]
8. Periocular injection of an adenoviral vector encoding pigment epithelium-derived factor inhibits choroidal neovascularization.
Gehlbach P; Demetriades AM; Yamamoto S; Deering T; Duh EJ; Yang HS; Cingolani C; Lai H; Wei L; Campochiaro PA
Gene Ther; 2003 Apr; 10(8):637-46. PubMed ID: 12692592
[TBL] [Abstract][Full Text] [Related]
9. Suppression of choroidal neovascularization by adeno-associated virus vector expressing angiostatin.
Lai CC; Wu WC; Chen SL; Xiao X; Tsai TC; Huan SJ; Chen TL; Tsai RJ; Tsao YP
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2401-7. PubMed ID: 11527956
[TBL] [Abstract][Full Text] [Related]
10. AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization.
Mori K; Gehlbach P; Yamamoto S; Duh E; Zack DJ; Li Q; Berns KI; Raisler BJ; Hauswirth WW; Campochiaro PA
Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1994-2000. PubMed ID: 12037010
[TBL] [Abstract][Full Text] [Related]
11. Suppression of choroidal neovascularization by intramuscular polymer-based gene delivery of vasostatin.
Sheu SJ; Chou LC; Bee YS; Chen JF; Lin HC; Lin PR; Lam HC; Tai MH
Exp Eye Res; 2005 Dec; 81(6):673-9. PubMed ID: 15967435
[TBL] [Abstract][Full Text] [Related]
12. Intraocular gene transfer of pigment epithelium-derived factor rescues photoreceptors from light-induced cell death.
Imai D; Yoneya S; Gehlbach PL; Wei LL; Mori K
J Cell Physiol; 2005 Feb; 202(2):570-8. PubMed ID: 15316929
[TBL] [Abstract][Full Text] [Related]
13. Clinical and histological findings after intravitreal injection of bevacizumab (Avastin) in a porcine model of choroidal neovascularization.
Lassota N; Prause JU; Scherfig E; Kiilgaard JF; la Cour M
Acta Ophthalmol; 2010 May; 88(3):300-8. PubMed ID: 19416113
[TBL] [Abstract][Full Text] [Related]
14. Retinal neuroprotection against ischemic injury mediated by intraocular gene transfer of pigment epithelium-derived factor.
Takita H; Yoneya S; Gehlbach PL; Duh EJ; Wei LL; Mori K
Invest Ophthalmol Vis Sci; 2003 Oct; 44(10):4497-504. PubMed ID: 14507898
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization.
Murata T; He S; Hangai M; Ishibashi T; Xi XP; Kim S; Hsueh WA; Ryan SJ; Law RE; Hinton DR
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2309-17. PubMed ID: 10892878
[TBL] [Abstract][Full Text] [Related]
16. [Effects of matrix metalloproteinases inhibitor GM6001 on choroidal neovascularization].
Chen XG; He SZ
Zhonghua Yan Ke Za Zhi; 2012 Aug; 48(8):744-9. PubMed ID: 23141517
[TBL] [Abstract][Full Text] [Related]
17. Subconjunctival administration of bucillamine suppresses choroidal neovascularization in rat.
Yanagi Y; Tamaki Y; Obata R; Muranaka K; Homma N; Matsuoka H; Mano H
Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3495-9. PubMed ID: 12407161
[TBL] [Abstract][Full Text] [Related]
18. Suppression of choroidal neovascularization by vasohibin-1, a vascular endothelium-derived angiogenic inhibitor.
Wakusawa R; Abe T; Sato H; Sonoda H; Sato M; Mitsuda Y; Takakura T; Fukushima T; Onami H; Nagai N; Ishikawa Y; Nishida K; Sato Y
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3272-80. PubMed ID: 21345982
[TBL] [Abstract][Full Text] [Related]
19. [Role and possible mechanism of regulators of G-protein signaling 5 in development of experimental choroidal neovascularization].
Ye Z; Wang YS; Cai Y; Ma K
Zhonghua Yan Ke Za Zhi; 2010 Aug; 46(8):731-8. PubMed ID: 21054999
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of choroidal neovascularization by intravitreal ketorolac.
Kim SJ; Toma HS
Arch Ophthalmol; 2010 May; 128(5):596-600. PubMed ID: 20457981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
